1. Yaxuan Sun, Xiaohui Hu* (2024) Aberrant alternative splicing in cancer: Splicing events and their regulatory mechanisms (Review). Int J Oncol 65(3):90.（* 通讯作者）；
2. Xiaohui Hu, Masaya Ono, Nyam-Osor Chimge, Keisuke Chosa, Cu Nguyen, Elizabeth Melendez，Chih-Hong Lou, Punnajit Lim, John Termini, Keane K. Y. Lai, Patrick T. Fueger, Jia-Ling Teo, Yusuke Higuchi and Michael Kahn (2021) Differential Kat3 Usage Orchestrates the Integration of Cellular Metabolism with Differentiation. Cancers 13, 5884；
3. Keane K. Y. Lai#, Xiaohui Hu#, Keisuke Chosa#, Cu Nguyen, David P. Lin, Keith K. Lai, Nobuo Kato, Yusuke Higuchi, Sarah K. Highlander, Elizabeth Melendez, Yoshihiro Eriguchi, Patrick T. Fueger, Andre J. Ouellette, Nyam-Osor Chimge, Masaya Ono and Michael Kahn (2021) p300 Serine 89: A Critical Signaling Integrator and Its Effects on Intestinal Homeostasis and Repair. Cancers 13,1288 (#并列第一作者)；
4. Hu X, Harvey SE, Zheng R, Lyu J, Grzeskowiak CL, Powell E, Piwinica-Worms H, Scott KL, Cheng C (2020) The RNA-binding protein AKAP8 suppresses tumor metastasis by antagonizing EMT-associated alternative splicing. Nat Commun 11(1): 486；
5. Zhang H, Brown RL, Wei Y, Zhao P, Liu S, Liu X, Deng Y, Hu X, Zhang J, Gao XD, Kang Y, Mercurio AM, Goel HL, Cheng C (2019) CD44 splice isoform switching determines breast cancer stem cell state. Genes Dev 33(3-4): 166-179；
6. Huang H, Zhang J, Harvey SE, Hu X, Cheng C (2017) RNA G-quadruplex secondary structure promotes alternative splicing via the RNA-binding protein hnRNPF. Genes Dev 31(22): 2296-2309；
7. Tang L, Jin X, Hu X, Hu X, Liu Z, Yu L (2016) Glaucocalyxin A inhibits the growth of liver cancer Focus and SMMC-7721 cells. Oncol Lett 11(2):1173-1178；
8. He Q, He Q, Liu X, Wei Y, Shen S, Hu X, Li Q, Peng X, Wang L, Yu L (2014) Genome-wide prediction of cancer driver genes based on SNP and cancer SNV data. Am J Cancer Res 4(4):394-410；
9. Hu X-H, Ding L-Y, Huang W-X, Yang X-M, Xie F, Xu M, Yu L (2013) (-) – Epigallocatechin -3-gallate, a potential inhibitor to human dicarbonyl/l-xylulose reductase. J Biochem 154:167-175；
10. Xiaohui Hu, Xianmei Yang, Quanze He, Qi Chen, Long Yu (2014) Glyoxalase1 is up-regulated in hepatocellular carcinoma and is essential for HCC cell proliferation. Biotechnol Lett 36(2):257-63；
11. Huang W, Ding L, Huang Q, Hu H, Liu S, Yang X, Hu X, Dang Y, Shen S, Li J, Ji X, Jiang S, Liu JO, Yu L (2010) Carbonyl Reductase 1 as a Novel Target of (-)-Epigallocatechin Gallate Against Hepatocellular Carcinoma. Hepatology 52:703-714；
12. Liu G, Jiang S, Wang C, Jiang W, Liu Z, Liu C, Saiyin H, Yang X, Shen S, Jiang D, Zhou P, Han D, Hu X, Yi Q, Yu L (2012) Zinc finger tranion factor 191, directly binding to beta-catenin promoter, promotes cell proliferation of hepatocellular carcinoma. Hepatology 55:1830-1839；
